Is it justifiable to move the grade-1 Ki67 index cut-off from 3% to 5% for pancreatic neuroendocrine tumors as has been proposed? The cases that fall to 3-5% category have clinicopathologic characteristics closer to those > 5% Meeting Abstract
| Authors: | Reid, M.; Balci, S.; Bagci, P.; Saka, B.; Pehlivanoglu, B.; Seven, I. E.; Basturk, O.; Adsay, N. V. |
| Abstract Title: | Is it justifiable to move the grade-1 Ki67 index cut-off from 3% to 5% for pancreatic neuroendocrine tumors as has been proposed? The cases that fall to 3-5% category have clinicopathologic characteristics closer to those > 5% |
| Meeting Title: | 109th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) |
| Journal Title: | Laboratory Investigation |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Feb 29-Mar 5 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 0023-6837 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-03-01 |
| Start Page: | 1673 |
| Language: | English |
| ACCESSION: | WOS:000518328803465 |
| PROVIDER: | wos |
| PUBMED: | 32139842 |
| DOI: | 10.1038/s41374-020-0397-4 |
| Notes: | Meeting Abstract: 1783 -- Source: Wos |
